You are here

Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Clinique Rambot La Provençale Tour d'Aygosi
Aix En Provence, , 13100 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chemotherapy-Induced Neutropenia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients aged at least 18 years, seen by the oncologist for chemotherapy for solid
tumour.

- Patients for whom the oncologist has decided the initiation of G-CSF biosimilar
treatment (Nivestim®) in primary or secondary prophylaxis.

- Patients informed about the computer processing of their medical data and their right
of access and correction.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients with contraindication of use of Nivestim®.

- Patients with haematological malignancy including Myelodysplasia and Chronic myeloid
leukemia treated or untreated.

- Patients participating or having participated in the previous month in a clinical
trial.

- Patients refusing to participate in this study.

NCT02454530
Pfizer
Completed
Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Chemotherapy-Induced Neutropenia
NCT02454530
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now